Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2]
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 μg | 約 35 days | ¥ 76,500 |
50 μg | 約 35 days | ¥ 144,500 |
100 μg | 約 35 days | ¥ 271,000 |
説明 | LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2] |
別名 | LTF4 |
分子量 | 568.72 |
分子式 | C28H44N2O8S |
CAS No. | 83851-42-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: >50 mg/mL (per Ramki Iyer)
Ethanol: >50 mg/mL (per Ramki Iyer)
DMSO: >50 mg/mL (per Ramki Iyer)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Leukotriene F4 83851-42-7 LTF4 LTF-4 LTF 4 Leukotriene F-4 Inhibitor inhibitor inhibit